09:00 - 09:30||
- Simão Campos, Counsellor, ITU-T Study Group 16 "Multimedia" [ Biography ]
- Gao Jun, Coordinator of Regional Office for the Western Pacific, World Health Organization (WHO)
- Xu Weiling, Director of Secretariat of ITU Working Committee, Ministry of Industry and Information Technology
09:30 - 11:00||
Session 1: Focus Group on AI for Health|
The session will frame the AI4H workshop by providing an overview of the activities of the FG and the topics and aspects that the FG and workshop would like to address including opportunities for standardization of AI solutions for health. It will highlight how AI and machine learning can revolutionize healthcare in the areas of clinical decision support, personalized medicine, augmented diagnosis capabilities, medical imaging interpretation, therapeutic purposes and disease prevention. The
session will provide an overview of the process and methodology of benchmarking AI algorithms for health, along with approaches and challenges to algorithms assessment. It will discuss how standardization process can lead to responsible adoption of algorithmic decision-making tools and to improving the accuracy of the algorithms. It will describe the proposal of a highly available system/ infrastructure for benchmarking the algorithms.
- Share understanding, considerations and work plans of the Focus Group.
- Identify standardization opportunities for a benchmarking framework that will enable the broad adoption of AI for health (AI4H).
- Process to apply the benchmark dataset for testing new algorithms.
- What are different types of benchmarking we want to do.
- How to set-up an open source testing infrastructure that will allow 24h testing system to operate.
Thomas Wiegand, FG-AI4H Chair, Fraunhofer HHI, Germany [
Naomi Lee, FG-AI4H Vice-Chair, Executive Director (Digital), The Lancet, United Kingdom [
Shan Xu, FG-AI4H Vice-Chair, CAICT, China
Ramesh Krishnamurthy, FG-AI4H Vice-Chair, WHO [
| 10:30 - 11:00||
11:00 - 12:30||
Session 2: Use Cases and Data Availability|
How can artificial intelligence assist humans in diagnostics and medical decision making? This session will provide best practices for the applications of AI in Health, covering different medical and health domains, e.g. radiology and ophthalmology, and will create a common ground for further discussions and for the subsequent workshop sessions.
Moderator: Naomi Lee, FG-AI4H Vice-Chair, Executive Director (Digital), The Lancet, United Kingdom [
- Kang Zhang, UC San Diego
- Chen Kuan, Founder and CEO, Infervision
- Ian Mathews, NUS, Singapore
- Kyu-Hwan, Vuno, Seoul
12:30 - 14:00||
14:00 - 15:30||
Benchmarking and Security|
This session will address the issue of availability of data sources for training and testing of the algorithms in the context of evaluation and validation with open benchmarks. It will address the need of open data sources and opportunities for how to make algorithms fair and unbiased, how to promote algorithmic accountability and how to make predictions equitable. It will describe the importance of having standardized formats for data input and data output in order to come up with some assessment/benchmark for algorithms.
Moderator: Shan Xu
Liu Wenli, Director, Medical Biology Department, China Metrology Institute
- Yu Weihong, Professor, Peking Union Medical College Hospital
- Liang Huiying, Director, Guangzhou Women and Children Medical Center
- Wu Zhenzhou, Chief Technology Officer, BioMind
15:30 - 16:00||
16:00 - 17:30||
Session 4: Regulations and Country priorities for use of AI for health|
This session will discuss existing AI initiatives in countries, related AI strategies, AI adoption maturity models, and priority health use cases that can benefit from AI for Health. The session will also highlight the need to align the health solutions with WHO global goals for health in terms of health outcomes, scalability and inclusiveness.
Moderator: Ramesh Krishnamurthy, WHO
Liang Peng, Deputy Director, Center for Medical Device Evaluation(CMDE), National Medical Products Administration(NMPA), Government of China
- Kazumi Nishikawa, Director, Healthcare Industries Division, Ministry of Economy, Trade and Industry, Government of Japan
- Chandrashekar Ranga, Deputy Drugs Controller of Central Drugs Standard Control Organisation (CDSCO) under Ministry of Health & Family Welfare, Government of India
- Yang Ziyi, China Academy of Information and Communication Technology, Ministry of Industry and Information Technology, Government of China
|17:30 - 17:45||Closing Session and Next Steps|
Ideas, issues and proposals stemming from the sessions will be compiled and prioritized according to the themes and critical areas of work established for the focus group. Each proposal will provide directions needed to be dealt with by the focus group. A list of issues and recommendations will be presented for consideration to the focus group on AI4H meeting.